Additionally, just over 60% of CFOs view the work from home model as a significant priority for the foreseeable future.
Nearly half of CFOs from the healthcare and life sciences sector expect their 2020 revenues to grow by 3% year-over-year, according to an Everest Group survey supported by WNS released Thursday morning.
Overall, a slight majority of CFOs anticipate revenues will grow by 3%, though finance executives still maintain concerns about market uncertainty going forward.
In light of the ongoing COVID-19 pandemic, almost half of surveyed CFOs said they are "not very confident" committing to investments over the next six to 12 months.
The top four concerns for CFOs are lower demand from consumers, issues with working capital and liquidity, supply chain continuity, as well as cost-base and pricing pressures.
Additionally, just over 60% of CFOs view the work from home model as a significant priority for the foreseeable future.
Jack O'Brien is the Content Team Lead and Finance Editor at HealthLeaders, an HCPro brand.